메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Kim, Sang Bum (Department of Pediatrics, Ajou University School of Medicine) Lee, Jang Hoon (Department of Pediatrics, Ajou University School of Medicine) Lee, Juyoung (Department of Pediatrics, Seoul National University College of Medicine) Shin, Seung Han (Department of Pediatrics, Seoul National University College of Medicine) Eun, Ho Sun (Department of Pediatrics, Yonsei University College of Medicine) Lee, Soon Min (Department of Pediatrics, Yonsei University College of Medicine) Sohn, Jin A (Department of Pediatrics, Seoul National University College of Medicine) Kim, Han Suk (Department of Pediatrics, Seoul National University College of Medicine) Choi, Byung Min (Department of Pediatrics, Korea University Ansan Hospital) Park, Min Soo (Department of Pediatrics, Yonsei University College of Medicine) Park, Kook In (Department of Pediatrics, Yonsei University College of Medicine) Namgung, Ran (Department of Pediatrics, Yonsei University College of Medicine) Park, Moon Sung (Department of Pediatrics, Ajou University School of Medicine)
저널정보
대한소아청소년과학회 Clinical and Experimental Pediatrics Korean journal of pediatrics 제58권 제9호
발행연도
2015.1
수록면
347 - 353 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose: The purpose of this study was to evaluate the efficacy and safety of Montelukast sodium in the prevention of bronchopulmonarydysplasia (BPD). Methods: The Interventional study was designed as a multicenter, prospective, and randomized trial, with open labeled and parallel-experimental groups, 66 infants were enrolled and allocated to either the case group (n=30) or the control group (n=36) based on gestational age (GA). Infants in the case group were given Montelukast sodium (Singulair) based on their body weight (BW). Zero week was defined as the start time of the study. Results: The incidence of moderate to severe BPD was not different between the groups (case group: 13 of 30 [43.3%] vs. control group: 19 of 36 [52.8%], P=0.912). Additionally, secondary outcomes such as ventilation index, mean airway pressure and resort to systemic steroids were not significantly different. There were no serious adverse drug reactions in either group, and furthermore the rate of occurrence of mild drug related-events were not significantly different (case group: 10 of 42 [23.8%] vs. control group: 6 of 48 (15.8%), P=0.414). Conclusion: Montelukast was not effective in reducing moderate or severe BPD. There were no significant adverse drug events associated with Montelukast treatment.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0